Original document(53 pages)  中文版
    The present invention is directed to azetidine compounds that inhibit the glycine transporter GlyT1 and which are useful in the treatment of neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction and diseases in which the glycine transporter GlyT1 is involved.
Application Number
申请号		 200580013270 Application Date
申请日		 2005.04.25
Title 名称 Azetidine glycine transporter inhibitors
Publication Number
公开号		 1946685 Publication Date
公开日		 2007.04.11
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D205/04;C07D401/04;C07D401/06;C07D413/04;C07D413/06
Applicant(s) Name
申请人		 Merck & Co. Inc.
Address 地址
Inventor(s) Name 发明人 Lindsley Craig W.;Hallett David;Wolkenberg Scott E.
Attorney & Agent 代理人 liuyuan jin liuyue
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.